Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
19 December 2017 10:13
Around 7,400 British women are diagnosed with ovarian cancer each year
A breakthrough ovarian cancer treatment has been launched in Britain, with the potential to prolong patients' lives and hold back the cancer - reducing relapse times.
The once-a-day pill, named Niraparib, is part of a new class of drugs that target cancers with defective DNA repair systems.
New hope for patients
This latest trial shows Niraparib can massively increase the length of time before cancer returns following chemotherapy.
Results show that for some women - those with an inherited BRCA gene mutation - the length of time before reoccurrence increased from five and a half months to 21 months, when compared with patients undergoing chemotherapy treatment alone.
The study also shows that women without the BRCA mutation benefit from the drug, experiencing double their relapse times.
"Niraparib is the first treatment of its class licensed to delay the progression of ovarian cancer following platinum-based chemotherapy, regardless of BRCA status," says Professor Jonathan Ledermann, from the University College London Cancer Institute.
He continued: "This represents a critical milestone in the management of ovarian cancer. Access to effective and tolerable medicines is sorely needed and the hope is that niraparib will be available in the NHS as quickly as possible."
'Nationwide roll-out'
Around 7,400 women are diagnosed with ovarian cancer each year in Britain, with around 85% of patients seeing it reoccur after treatment.
The cost of the treatment and benefits to the patients are weighed up by the National Institute for Health and Care Excellence (Nice) in England and Wales and the Scottish Medicines Consortium in Scotland.
Katherine Taylor, chief executive of the charity Ovarian Cancer Action, said: "Today's news is an encouraging step in the right direction but we now need to ensure all UK women diagnosed with recurrent platinum-sensitive ovarian cancer can benefit.
"We call upon the National Institute for Health and Care Excellence and the Scottish Medicines Consortium to approve this drug to provide more treatment options for those diagnosed with ovarian cancer - for many women this could be life changing."
Whatever stage your cancer is at, we may still be able to cover you for holidays and overseas travel with our specialist cancer travel insurance.
19 April 2018
A self-injected smart drug may be the key to easing and preventing pain for migraine sufferers.
[more...]
17 April 2018
Despite its reputation as a party drug, ketamine is licensed as an anaesthetic. A recent US study found use of the drug via a nasal spray led to "significant" improvements in depressive symptoms in the first 24 hours.
Simple brain-training exercises carried out at home have been shown to reduce emotional stress in female breast cancer survivors, it's recently been revealed.
13 April 2018
Drinkers who consume more alcohol than UK guidelines suggest could be cutting years off their lives, according to new research.
12 April 2018
A recent study has revealed that people who sustain brain injuries are at an increased risk of developing dementia later in life.
11 April 2018
Scientists have announced their latest breakthrough in the battle against Alzheimer's disease, after neutralising a high-risk gene in a human brain cell for the first time.
07 April 2018
The Philippines is set to shut its most famous holiday island of Boracay for six months, after the President described it as a "cesspool".
05 April 2018
Taxes on soft drinks, alcohol and tobacco - nicknamed "sin taxes" - could be a powerful step towards combating rising rates of chronic diseases worldwide, research has suggested.
New "one-stop shops" to speed up cancer diagnosis are being trialled across the country for the first time.
30 March 2018
Doctors should tell patients that e-cigarettes are less harmful than smoking but not without risk, according to new national guidance.
29 March 2018
Young people suffering from mental health problems are finding it hard to get the support they need, a survey has revealed.
28 March 2018
Children exposed to epilepsy drugs in the womb may achieve poorer test results at school, a study has suggested.